Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Mataró
Clinical trial register · Spain

Clinical Trials in Mataró, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Spain and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5881 matching records held by the registry are in this view. Synced 14 Oct 2026, 03:19 UTC
5881
Studies in scope
all four open statuses
3099
Recruiting now
open to new participants
1137
Lead sponsors
across recruiting studies
Top sites
Barcelona 3244 Madrid 3050 Valencia 1215 Seville 1056 Málaga 750
Narrow the registerReset
Recruitment status
Phase
Site location
Barcelona3244 Madrid3050 Valencia1215 Seville1056 Málaga750
All 453 locations
Target enrolment
to

Trials with a site in Mataró

21 of 5881 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Spain
Start
Not yet open
Aesculap AG
Observational
110
Badalona, Calella, Mataró, Santa Coloma de Gramenet
2026-09
Recruiting
AstraZeneca
Phase 3
600
Barcelona, Figueres, La Roca del Vallès, Mataró, Viladecans
2026-08-12
Recruiting
Home tDCS for the Treatment of Major Depression.
NCT07510880Major Depression Disorder
Ionclinics & Deionic SL
Not applicable
198
L'Hospitalet de Llobregat, Mataró, Sabadell
2026-04-14
Not yet open
Effectiveness of Combined Super Inductive System (SIS) Therapy With Therapeutic Exercise and Health Education in Lateral Elbow Tendinopathy
NCT07495254Lateral Epicondylitis (Tennis Elbow), Lateral Epicondylalgia, Lateral Elbow Tendinopathy
University of Vic - Central University of Catalonia
Not applicable
224
Mataró
2026-03-30
Recruiting
Kymera Therapeutics, Inc.
Phase 2
264
Cadiz, Jerez de la Frontera, Madrid, Mataró, Santander
2026-01-28
Recruiting
A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer
NCT07169851Nausea, Vomiting, Drug-Related Side Effects and Adverse Reactions, Neoplasms
Eli Lilly and Company
Phase 2
204
Barcelona, Madrid, Mataró, Málaga, Reus
2025-11-28
Recruiting
Effect of Micronized Creatine Monohydrate on Muscle Mass, Strength and Performance in Older Adults Submitted to Total Knee Arthroplasty
NCT06925880Sarcopenia in Elderly, Frailty at Older Adults, Functional Capacity, Creatine Supplementation
Consorci Sanitari del Maresme
Not applicable
262
Mataró
2025-06-10
By invitation
Braingaze
Not applicable
60
Mataró
2025-05-01
Recruiting
Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa
Observational
153
Vitoria-Gasteiz, Badalona, L'Hospitalet de Llobregat, Manresa, Mataró, Terrassa, Viladecans, Torrelavega
2025-04-14
Active, closed
Pharmacokinetic Similarity Between ABP 234 and Keytruda® (Pembrolizumab)
NCT06430866Early-stage Non-squamous Non-small Cell Lung Cancer (NSCLC)
Amgen
Phase 3
163
A Coruna Galicia, A Coruña, Alicante, Badalona, Barcelona, Jerez de la Frontera, Madrid, Mataró
2024-09-12
Active, closed
Amgen
Phase 3
315
Alicante, Barcelona, Jaén, Madrid, Mataró, Málaga, Oviedo, Seville
2024-09-09
Active, closed
Fundación GECP
Phase 2
22
Alicante, Barcelona, Mataró, Bilbao, Cáceres, Jerez de la Frontera, Girona, Jaén
2023-05-12
Active, closed
Three Antidiarrheal Strategies in HER2+/HR+ Early Breast Cancer Patients Treated With Extended Adjuvant Neratinib
NCT05252988Early-stage Breast Cancer, HER2 Positive Breast Cancer, Hormone Receptor Positive
Spanish Breast Cancer Research Group
Phase 2
177
Elche, Málaga, Zaragoza, L'Hospitalet de Llobregat, Manresa, Mataró, Castellon, Valladolid
2022-08-31
Recruiting
Innovacell GmbH
Phase 3
290
Barcelona, Mataró, Murcia, Oviedo
2022-05-11
Active, closed
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina
Observational
1,300
Mataró
2022-04-01
Active, closed
Guardant Health, Inc.
Observational
12,000
Benalmádena, Valladolid, Mataró, Boadilla del Monte, Madrid, Móstoles
2022-01-13
Active, closed
Eli Lilly and Company
Phase 3
152
Santiago de Compostela, Cadiz, Córdoba, Badalona, Barcelona, L'Hospitalet Del Llobregat, Mataró, León
2021-12-20
Active, closed
Fondazione Ricerca Traslazionale
Phase 2
105
A Coruña, Barcelona, Madrid, Mataró, Málaga
2021-10-12
Recruiting
ALND vs ART in Positive Sentinel Node After Neoadjuvant Therapy in Breast Cancer
NCT04889924Breast Cancer, Chemotherapy, Sentinel Lymph Node, Axillary Lymph Nodes Dissection
Hospital Universitari de Bellvitge
Not applicable
820
Badalona, Calella, Granollers, L'Hospitalet de Llobregat, Manresa, Mataró, Sant Cugat del Vallès, Terrassa
2021-06-11
Recruiting
Integrative Diagnosis for SCD and Other RADs
NCT07206095Sickle Cell Disease, Thalassaemia, Congenital Dyserythropoietic Anemia (CDA), Enzyme Disorder; Anemia
Hospital Universitari Vall d'Hebron Research Institute
Observational
200
Barcelona, Esplugues de Llobregat, Granollers, Mataró, Sabadell, Terrassa, Lleida
2020-11-13
Active, closed
Avelumab Program Rollover Study
NCT03815643Solid Tumors
EMD Serono Research & Development Institute, Inc.
Phase 3
205
Barcelona, Madrid, Mataró
2019-03-22
Rows per page Showing 1–21 of 21
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Spanish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 14 October 2026. https://priyalifescience.com/clinical-trials-spain/city/matar

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Spain and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,881 studies in total at the last sync on 14 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 21 of those studies with a site in Mataró.

How many clinical trials are recruiting in Mataró?

9 of the 21 studies on this page are recruiting new participants as of the 14 Oct 2026, 03:19 UTC sync. A further 2 have not yet opened recruitment, 9 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Mataró), 21 studies
PhaseStudiesRecruitingShare
Phase 36228.6%
Not applicable5323.8%
Observational5223.8%
Phase 25223.8%

Most active sponsors

Lead sponsors with the most studies (Mataró)
Lead sponsorStudiesRecruiting
Amgen20
Eli Lilly and Company21
Aesculap AG10
AstraZeneca11
Braingaze10
Consorci Sanitari del Maresme11
EMD Serono Research & Development Institute, Inc.10
Fondazione Ricerca Traslazionale10
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina10
Fundación GECP10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.